Southcoast Health opens a second Hybrid Operating Room at Charlton Memorial, expanding access to advanced heart and vascular care.

Long-term results from the Hydra CE Study highlight durable valve function, stable hemodynamics, and a favourable safety ...

The global Transcatheter Cardiac Valve Replacement (THVR) market, valued at USD 6.54 billion in 2023, is on a robust growth trajectory, projected to expand at a compound annual growth rate (CAGR) of ...

Additionally, several new trials reporting longer-term follow-up on MICS coronary and valve surgery have demonstrated durable ...

JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced the completion of its 1,000th commercial Trilogy procedure, performed in ...

The TARGET Study Interim Results: "Safety and Performance of the Cardiovalve Replacement System for Tricuspid Regurgitation" ...

Exciting Data on Cardiovalve Tricuspid Valve Replacement Device Presented at PCR London Valves 2025 meeting. LONDON, Nov. 17, 2025 /PRNewswire/ -- Venus Medtech (Hangzhou) ...

Late-breaking results from clinical trials, debates about lifestyle choices and cardiovascular risk, and improving clinical care with generative AI are among the topics being presented by UC San ...

Pediatric interventional cardiology has emerged as a specialized field that integrates pediatric cardiology with interventional techniques to diagnose and treat heart defects in infants, children, and ...

ViTAA Medical’s aortic surgery planning tool has gained clearance from the US Food and Drug Administration (FDA), ...

A new whitepaper from Alleima explores how guidewire technology is evolving with the growing prevalence of chronic conditions ...